Histological classification of prostate cancer with clinicopathological implication
Harada, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 76-81
2002
ISSN/ISBN: 0047-1852 PMID: 12599549 Document Number: 549386
Document emailed within 1 workday
Related Documents
Vacherot, F.; Terry, Séphane.; Faucon, H.; Queires, L.; Chen, M-Wei.; Yang, X.; Gil Diez de Medina, S.; Verdier, A.; Azoulay, S.; Allory, Y.; Abbou, C.C.; Buttyan, R.; de la Taille, A. 2005: Protocadherin-PC discovery and its implication in prostate cancer progression Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(6 Suppl. 1): 1294-1302Giannakopoulos, X.; Stagikas, D.; Peschos, D.; Batistatou, A.; Charalabopoulos, K. 2007: Implication of protocadherin-PC in the progression of the advanced prostate cancer Experimental Oncology 29(1): 74-75
Shimoda, T.; Nimura, S.; Tominaga, K.; Ogawa, M.; Fujimoto, Y.; Nakanishi, Y. 2001: Clinicopathological findings and histological appearance of early gastric cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 142-155
Chen, H.-J.; Wang, H.; Zhang, L.; Zhang, Y.-K.; Wang, G.-M. 2006: Correlation between integrin subunits alpha5 and beta1 expressions in prostate cancer and its clinical implication Zhonghua Nan Ke Xue 12(2): 148-150
Hayashi, Y.; Ohwada, H. 1980: Histological classification of lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2565-2573
Hedinger, C. 1977: Histological classification of thyroid cancer Annales de Radiologie 20(8): 696-699
Harada, M. 2000: Histopathological classification of prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 61-66
Chen, J.; Quan, C-Yi.; Chang, J-Wu.; Yang, Y-Ming.; Li, B.; Chang, W-Liang.; Wang, J.; Niu, Y-Jie. 2011: Prostate cancer with five different histological features: a case report and review of the literature Zhonghua Nan Ke Xue 17(9): 825-828
Mönig, S.; Baldus, S.E.; Collet, P.H.; Zirbes, T.K.; Bollschweiler, E.; Thiele, J.; Dienes, H.P.; Hölscher, A.H. 2001: Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis Anticancer Research 21(1b): 617-620
Zhang, M.; Yang, R.; Wang, W.; Li, X.; Zhang, Y.; Guo, H. 2015: Clinicopathological implications of single positive core prostate cancer in a 12-core transrectal biopsy scheme Zhonghua Yi Xue Za Zhi 95(20): 1602-1605
Logothetis, C.J. 1999: Introduction: a therapeutically relevant framework for the classification of human prostate cancer Seminars in Oncology 26(4): 369-374
Serrano, N.A.; Anscher, M.S. 2016: Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: a Review of the new Classification System and its Impact on Treatment Recommendations Oncology 30(3): 229-236
Thiele, J.; Fohlmeister, I.; Vonneguth, B.; Zankovich, R.; Fischer, R. 1986: The prognostic implication of clinical and histological features in Ph1+ chronic myelocytic leukaemia (CML) Anticancer Research 6(6): 1401-1409
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Noda, N. 1970: Histological classification of gastric carcinoma--histological study according to histogenesis and biological characteristics of intestinal-type carcinoma and diffuse carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(8): 786-797
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747